RFG Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
15,408
-10,178
-40% -$821K 0.02% 507
2026
Q1
$2.22M Buy
25,586
+439
+2% +$42.1K 0.04% 320
2025
Q4
$2.42M Sell
25,147
-3,384
-12% -$329K 0.05% 293
2025
Q3
$2.72M Buy
28,531
+3,096
+12% +$285K 0.06% 257
2025
Q2
$2.22M Sell
25,435
-539
-2% -$45.7K 0.05% 279
2025
Q1
$2.33M Buy
25,974
+1,482
+6% +$133K 0.06% 244
2024
Q4
$1.96M Buy
24,492
+274
+1% +$23.7K 0.06% 256
2024
Q3
$2.18M Sell
24,218
-732
-3% -$61.6K 0.07% 228
2024
Q2
$1.96M Buy
24,950
+1,874
+8% +$154K 0.06% 220
2024
Q1
$2.01M Buy
23,076
+1,134
+5% +$96.8K 0.07% 219
2023
Q4
$1.81M Sell
21,942
-8,154
-27% -$621K 0.07% 210
2023
Q3
$2.36M Buy
30,096
+6,130
+26% +$513K 0.11% 148
2023
Q2
$2.11M Buy
23,966
+13,285
+124% +$1.14M 0.09% 158
2023
Q1
$861K Buy
10,681
+74
+0.7% +$6.03K 0.04% 306
2022
Q4
$924K Buy
10,607
+394
+4% +$31.9K 0.05% 290
2022
Q3
$819K Sell
10,213
-1,756
-15% -$158K 0.05% 290
2022
Q2
$1.12M Buy
11,969
+3,550
+42% +$360K 0.06% 218
2022
Q1
$934K Sell
8,419
-2,560
-23% -$270K 0.06% 204
2021
Q4
$1.14M Buy
10,979
+2,382
+28% +$276K 0.08% 174
2021
Q3
$1.08M Buy
8,597
+991
+13% +$128K 0.09% 161
2021
Q2
$944K Sell
7,606
-544
-7% -$68.3K 0.08% 175
2021
Q1
$963K Buy
8,150
+303
+4% +$35.5K 0.1% 155
2020
Q4
$939K Sell
7,847
-1,342
-15% -$148K 0.12% 156
2020
Q3
$955K Buy
9,189
+823
+10% +$82.7K 0.13% 143
2020
Q2
$767K Buy
8,366
+864
+12% +$82.8K 0.12% 158
2020
Q1
$677K Buy
7,502
+990
+15% +$105K 0.13% 151
2019
Q4
$739K Buy
6,512
+3,300
+103% +$362K 0.13% 152
2019
Q3
$349K Buy
3,212
+736
+30% +$76.8K 0.07% 218
2019
Q2
$239K Buy
+2,476
New +$226K 0.05% 266

Other funds holding MDT

RFG Advisory's MDT Position: Q2 2026 in Review

RFG Advisory reduced its Medtronic (MDT) stake by 40% in Q2 2026, selling an estimated $821K and leaving 15,408 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #507.

RFG Advisory first reported a position in MDT in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.72M in Q3 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • RFG Advisory held 15,408 shares of Medtronic worth $1.21M as of Q2 2026.
  • RFG Advisory sold 10,178 Medtronic shares in Q2 2026, an estimated $821K.
  • Medtronic made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #507 holding.
  • RFG Advisory first reported a position in Medtronic in Q2 2019 and has held it in 29 quarters since.
  • RFG Advisory's Medtronic position peaked at $2.72M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.